Drug research

ATH434 dose level 1

Open a linked trial to see its study details and recorded changes, or check the regulatory events below and follow their sources.

Drug identity checked against registry records

Also recorded as PBT434

A drug appearing in a clinical trial does not mean it is FDA-approved. Check the original regulatory source for any approval claim.

Included trials

Trial	Sponsor	Phase	Status	Primary completion
Study of ATH434 in Participants with Multiple System AtrophyNCT05109091	Alterity Therapeutics	Phase 2	Completed	2024-11-28Actual

Alterity TherapeuticsCompletedPrimary completion: 2024-11-28 · Actual

Trial details

No regulatory events match this view.Try another date range or view. Events appear after automated source checks. This does not mean no FDA events have occurred. Dates that a source does not disclose stay undisclosed.